Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer

BMC Cancer

Table 2 Response and adverse of neoadjuvant chemotherapy among patients with locally advanced oral cavity cancer

	Undergoing surgery (N = 148)	Without surgery (N = 23)	Χ² value	P - value
Response ^a			0.401	0.859
PR	81	14
SD	60	8
PD	7	1
Adverse events ^b
WBC decreased			0.254	0.614
Grade 0/1	137	20
Grade 2/3	11	3
Vomiting			9.082	0.003
Grade 0/1	143	18
Grade 2/3	5	5

^a The response definitions were classified according to the Response Evaluation Criteria in Solid Tumors version 1.1
^b The adverse events were graded according to National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0

ISSN: 1471-2407